Why the study?
Does sustained-release verapamil reduce blood pressure in patients with mild to moderate uncomplicated essential hypertension?
Population
19 patients aged 36-70 years with mild to moderate, uncomplicated essential hypertension
Design
Cohort
Follow-up
8 weeks
Authors
Loading...
Sustained-release verapamil 240 mg once daily effectively lowers blood pressure and is well tolerated as a first-line treatment for mild to moderate essential hypertension.
Does sustained-release verapamil reduce blood pressure in patients with mild to moderate uncomplicated essential hypertension?
Sustained-release verapamil 240 mg once daily effectively lowers blood pressure and is well tolerated as a first-line treatment for mild to moderate essential hypertension.
Karcier et al. (1989) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: